期刊文献+

减小非小细胞肺癌三维适形放射治疗靶体积可行性剂量学研究 被引量:1

Feasibility of target volume reduction in three-dimensional conformal radiotherapy for non-small cell lung cancer: a dosimetry study
暂未订购
导出
摘要 目的从剂量学探讨减小非小细胞肺癌三维适形放射治疗照射体积的可行性。方法32例非小细胞肺癌患者均做2个放射治疗计划:常规照射野三维适形放射治疗计划和小野三维适形放射治疗计划,用剂量体积直方图评估肿瘤靶区剂量和正常组织受照剂量。结果小野三维适形放射治疗仍能满足肿瘤靶区剂量的要求,亚临床灶的最小剂量、最大剂量和平均剂量分别为50.93Gy、54.60Gy和(52.37±1.02)Gy。与常规适形野相比,小野适形放疗减少了患侧肺、脊髓和食管的平均剂量(P〈0.05)。结论缩小非小细胞肺癌三维适形放射治疗照射野能满足肿瘤靶区剂量的需要,同时降低了正常组织的受照剂量,可在临床开展相关研究。 Objective To investigate the dosimetry and feasibility of target volume reduction in three-dimensional conformal radiotherapy for non-small cell lung cancer(NSCLC). Methods Two differ- ent radiation treatment planning, the conventional conformal planning and the small volume conformal plan- ning,were designed for 32 NSCLC patients. Dose-olume histograms were used to assess the dosimetric dis- parity in target regions and surrounding organs at risk. Results Small volume conformal planning could meet the demand of target dose. The least dose, the maximum dose, and the mean dose at subclinical targets were 50.93 Gy,54.60 Gy and(52.37 ± 1.02) Gy,respectively. Comparing with the conventional conformal planning, small volume conformal planning reduced the mean dose of tung, spinal cord and esophagus(P 〈 0.05). Conclusion Small volume conformal planning can meet the dosimetric requirement of target vol- ume for NSCLC and reduce the dose of normal tissues, which is worthy of further clinical study.
作者 钟亚华
机构地区 [
出处 《临床外科杂志》 2014年第9期692-694,共3页 Journal of Clinical Surgery
基金 湖北省自然科学基金重点项目(编号:2013CFA006)
关键词 非小细胞肺癌 三维适形放射治疗 靶体积 non-mall cell lung cancer three-dimensional conformal radiotherapy target volume
  • 相关文献

参考文献8

  • 1ICRU. Report 50. Prescribing, recording, and reporting photon beam therapy[ R]. International Commission on Radiation Units and Meas- urements, ICRU Publications, Bethesda, USA, 1993:3 -16.
  • 2李万龙,于金明,范廷勇,付政,刘希斌,仲伟霞,张利民.氟脱氧葡萄糖PET-CT对非小细胞肺癌纵隔淋巴结转移的诊断价值[J].中华放射肿瘤学杂志,2005,14(3):166-169. 被引量:20
  • 3Das U, Cheng EC, Anderson PR, et al. Optimum beam angles for the conformal treatment of lung cancer: a CT simulation study [ J ]. Int J Cancer,2000,90(6) :359-365.
  • 4Laine AM, Westover KD, Choy H. Radiation therapy as a backbone of treatment of locally advanced non-small cell lung cancer [ J ]. Semin Oncol,2014,41 ( 1 ) :57-68.
  • 5严四军,邓波荣,曹祥,谢念林,乔德成,刘燕.99例周围型小肺癌的TNM分期分析及临床意义探讨[J].临床外科杂志,2014,22(1):49-52. 被引量:7
  • 6Giraud P, Antoine M, Larrouy A, et al. Evaluation of microscopic tumor extension in non-small-cell lung cancer for three-dimensional eonformal radiotherapy plannin [ J ]. Int J Radiat Oncol Biol Phys, 2000,48(4) :1015-1024.
  • 7Spych M, Gottwald L, Klonowiez M, et al. The analysis of prognostic factors affecting post-radiation acute reaction after conformal radiother- apy for non-small cell lung cancer [ J ]. Arch Med Sci, 2010,6 ( 5 ) : 756-763.
  • 8Cai S, Shi A,Yu R, et al. Feasibility of omitting clinical target volume for limited-disease small cell lung cancer treated with chemotherapy and intensity-modulated radiotherapy [ J ]. Radiat Oncol, 2014,9 : 17.

二级参考文献32

  • 1Gupta NC, Tamim WJ, Graeber GG. Mediastinal lymph node sampling following positron emission tomography with fluorodeoxyglucose imaging in lung cancer staging. Chest,2001,120: 521-527.
  • 2Roman MR, Rossleigh MA, Angelides S, et al. Staging and managing lung tumor using F-18FDG coincidence detection. Clin Nucl Med, 2001,26: 383-388.
  • 3Townsend DW, Beyer TA. Combined PET/CT scanner: the path to true image fusion. Br J Radiol, 2002,75: S24-30.
  • 4Nakamoto Y, Osman M, Cohade C, et al. PET/CT: comparison of quantitative tracer uptake between germanium and CT transmission attenuation-corrected images. J Nucl,2002,43:1137-1143.
  • 5Nishioka T, Shiga T, Shirato H, et al. Image fusion between 18FDG-PET and MRI/CT for radiotherapy planning of oropharyngeal and nasopharyngeal carcinomas, Int J Radiat Oncol Biol Phys, 2002, 53:1051-1057.
  • 6Fritscher-Ravens A, Bohuslavizki KH, Brandt L, et al. Mediastinal lymph node involvement in potentially resectable lung cancer: comparison of CT, positron emission tomography, and endoscopic ultrasonography with and without fine-needle aspiration. Chest, 2003,123: 442-451.
  • 7Kernstine KH, Mclaughlin KA, Menda Y, et al. Can FDG-PET reduce the need for mediastinoscopy in potentially resectable nonsmall cell lung cancer? Ann Thorac Surg,2002,73: 394-401.
  • 8Tahara RW, Lackner RP. Is there a role for mediastinoscopy in patients with peripheral T1 lung cancers? Am J Surg,2000,180:488-491.
  • 9Jeffrey D. Bradley, Sasha Wahab, et al. Elective nodal failures are uncommon in medically inoperable patients with Stage I non-small-cell lung carcinoma treated with limited radiotherapy fields. Int J Radiat Oncol Biol Phys, 2003,56: 342-347.
  • 10Imdahl A, Jenkner S, Brink I, et al. Validation of FDG positron emission tomography for differentiation of unknown pulmonary lesions.Eur J Cardiothorac Surg,2001,20: 324-329.

共引文献25

同被引文献8

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部